Solx Inc.

Industry

  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
    • Implantable Devices
    • Biomaterials
  • Biotechnology
See more in Biomedtracker

Latest on Solx Inc.

Medtech Insight

Glaucoma Devices: Progress On Multiple Fronts

The worldwide glaucoma market, worth over $4 billion annually, has been dominated for decades by drug therapy, which accounts for approximately 95% of the total market. The emergence of a high-growth

Medtech Insight

Solx Inc.

Solx Inc. 230 Second Avenue Suite 120 Waltham, MA 02451 Phone: (781) 609-2016 Web Site: www.solx.com Contact: Douglas Adams, President & CEO Industry Segment: Ophthalmology Devices Busin

In Vivo

Start-Up Previews, June 2012

 
• By Nancy Dvorin

This month’s profile group, Atrial Fibrillation Agents: Better Drugs For The Arrhythmic Heart Improvements in targeting the sources of aberrant cardiac rhythms may open the heart up to new therapies.

Scrip

Recent Financings Of Private Companies (03/2012)

 
• By Deanna Kamienski, Beth Allan, Andrea Mancini, Amanda Micklus, Maureen Riordan, and Theresa Surprenant

IN VITRO DIAGNOSTICS On-Q-ity Inc. On-Q-ity closes $5mm Series B round On-Q-ity Inc. (has a circulating tumor cell technology for cancer diagnostics) raised $5mm through its Series B round. Mo